{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:11:06Z","timestamp":1777111866353,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-0967-3","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:03:42Z","timestamp":1554278622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study"],"prefix":"10.1186","volume":"19","author":[{"given":"Fotios S.","family":"Fousekis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos H.","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios I.","family":"Theopistos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Baltayiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kosmidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Glantzounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Christou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Epameinondas V.","family":"Tsianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-1160","authenticated-orcid":false,"given":"Dimitrios K.","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"issue":"27","key":"967_CR1","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.3748\/wjg.v20.i27.8783","volume":"20","author":"R Wang","year":"2014","unstructured":"Wang R, Leong RW. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol. 2014;20(27):8783\u20139.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"967_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","volume":"50","author":"MM Claessen","year":"2009","unstructured":"Claessen MM, Vieggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50(1):158\u201364.","journal-title":"J Hepatol"},{"issue":"1","key":"967_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12794","volume":"40","author":"E Gizard","year":"2014","unstructured":"Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40(1):3\u201315.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"967_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.21537","volume":"45","author":"F Parente","year":"2007","unstructured":"Parente F, Pastore L, Bargiggia S, Cucino C, Greco S, Molteni M, et al. Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study. Hepatology. 2007;45(5):1267\u201374.","journal-title":"Hepatology"},{"issue":"5","key":"967_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00004836-200305000-00012","volume":"36","author":"S Bargiggia","year":"2003","unstructured":"Bargiggia S, Maconi G, Elli M, Molteni P, Ardizzone S, Parente F, et al. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol. 2003;36(5):417\u201320.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"967_CR6","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/j.crohns.2012.10.015","volume":"7","author":"A Sourianarayanane","year":"2013","unstructured":"Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(8):e279\u201385.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"967_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0016-5085(86)90704-3","volume":"91","author":"SH Mir-Madjlessi","year":"1986","unstructured":"Mir-Madjlessi SH, McHenry MC, Farmer RG. Liver abscess in Crohn's disease. Report of four cases and review of the literature. Gastroenterology. 1986;91(4):987\u201393.","journal-title":"Gastroenterology"},{"issue":"10","key":"967_CR8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1023\/A:1026697613173","volume":"44","author":"M Koulentaki","year":"1999","unstructured":"Koulentaki M, Koutroubakis IE, Petinaki E, Tzardi M, Oekonomaki H, Mouzas I, et al. Ulcerative colitis associated with primary biliary cirrhosis. Dig Dis Sci. 1999;44(10):1953\u20136.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"967_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/gut.51.4.536","volume":"51","author":"RA Ransford","year":"2002","unstructured":"Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002;51(4):536\u20139.","journal-title":"Gut"},{"issue":"2","key":"967_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ibd.21820","volume":"18","author":"N Khan","year":"2012","unstructured":"Khan N, Abbas AM, Whang N, Balart LA, Bazzano LA, Kelly TN. Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Inflamm Bowel Dis. 2012;18(2):359\u201367.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"967_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"AG Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50(4):485\u20139.","journal-title":"Gut"},{"issue":"7","key":"967_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/MIB.0b013e318281f28f","volume":"19","author":"M Chaparro","year":"2013","unstructured":"Chaparro M, Ordas I, Cabre E, Garcia-Sanchez V, Bastida G, Penalva M, et al. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis. 2013;19(7):1404\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"967_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/apt.13159","volume":"41","author":"E Shelton","year":"2015","unstructured":"Shelton E, Chaudrey K, Sauk J, Khalili H, Masia R, Nguyen DD, et al. New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2015. May;41(10):972\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"967_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","volume":"3","author":"JF Rahier","year":"2009","unstructured":"Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3(2):47\u201391.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"967_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MCG.0b013e3181cadbe1","volume":"44","author":"CS Pitchumoni","year":"2010","unstructured":"Pitchumoni CS, Rubin A, Das K. Pancreatitis in inflammatory bowel diseases. J Clin Gastroenterol. 2010;44(4):246\u201353.","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"967_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/apt.12461","volume":"38","author":"A Douros","year":"2013","unstructured":"Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Ockenga J, et al. Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases. Aliment Pharmacol Ther. 2013;38(7):825\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"967_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1440-1827.2007.02112.x","volume":"57","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto T, Yamasaki S, Arakawa A, Abe K, Abe H, Kon K, et al. Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits. Pathol Int. 2007;57(6):388\u20139.","journal-title":"Pathol Int"},{"issue":"4","key":"967_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","volume":"6","author":"C Tsaitas","year":"2014","unstructured":"Tsaitas C, Semertzidou A, Sinakos E. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol. 2014;6(4):178\u201387.","journal-title":"World J Hepatol"},{"key":"967_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-230X-11-83","volume":"11","author":"E Toy","year":"2011","unstructured":"Toy E, Balasubramanian S, Selmi C, Li CS, Bowlus CL. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol. 2011;11:83.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"967_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1665-2681(19)31880-0","volume":"7","author":"G Vazquez-Elizondo","year":"2008","unstructured":"Vazquez-Elizondo G, Mucino-Bermejo J, Mendez-Sanchez N. Gallbladder disease in patients with primary sclerosing cholangitis. Ann Hepatol. 2008;7(2):182\u20133.","journal-title":"Ann Hepatol"},{"issue":"5","key":"967_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2036.2008.03746.x","volume":"28","author":"F Bermejo","year":"2008","unstructured":"Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Perez-Calle JL, Vera I, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28(5):623\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"967_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/00365529950173096","volume":"34","author":"HH Rasmussen","year":"1999","unstructured":"Rasmussen HH, Fonager K, Sorensen HT, Pedersen L, Dahlerup JF, Steffensen FH. Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study. Scand J Gastroenterol. 1999;34(2):199\u2013201.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"967_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00004836-199312000-00004","volume":"17","author":"P Weber","year":"1993","unstructured":"Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn's disease. J Clin Gastroenterol. 1993;17(4):286\u201391.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"967_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ajg.2008.4","volume":"104","author":"C Loras","year":"2009","unstructured":"Loras C, Saro C, Gonzalez-Huix F, Minguez M, Merino O, Gisbert JP, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol. 2009;104(1):57\u201363.","journal-title":"Am J Gastroenterol"},{"issue":"41","key":"967_CR25","doi-asserted-by":"publisher","first-page":"15358","DOI":"10.3748\/wjg.v20.i41.15358","volume":"20","author":"R Ben Musa","year":"2014","unstructured":"Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, et al. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014;20(41):15358\u201366.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"967_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.medcli.2008.07.013","volume":"132","author":"L Vida Perez","year":"2009","unstructured":"Vida Perez L, Gomez Camacho F, Garcia Sanchez V, Iglesias Flores EM, Castillo Molina L, Cerezo Ruiz A, et al. Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease. Med Clin (Barc). 2009;132(9):331\u20135.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"967_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/MIB.0b013e31827febe9","volume":"19","author":"JP Gisbert","year":"2013","unstructured":"Gisbert JP, Villagrasa JR, Rodriguez-Nogueiras A, Chaparro M. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(3):554\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"967_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"11","key":"967_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.crohns.2014.06.009","volume":"8","author":"C Loras","year":"2014","unstructured":"Loras C, Gisbert JP, Saro MC, Piqueras M, Sanchez-Montes C, Barrio J, et al. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3). J Crohns Colitis. 2014;8(11):1529\u201338.","journal-title":"J Crohns Colitis"},{"issue":"10","key":"967_CR30","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gut.2010.208413","volume":"59","author":"C Loras","year":"2010","unstructured":"Loras C, Gisbert JP, Minguez M, Merino O, Bujanda L, Saro C, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59(10):1340\u20136.","journal-title":"Gut"},{"issue":"7","key":"967_CR31","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","volume":"102","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gonzalez-Lama Y, Mate J. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2007;102(7):1518\u201327.","journal-title":"Am J Gastroenterol"},{"key":"967_CR32","doi-asserted-by":"crossref","unstructured":"de Jong DJ, Derijks LJ, Naber AH, Hooymans PM, Mulder CJ. Safety of thiopurines in the treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl. 2003;(239):69\u201372.","DOI":"10.1080\/00855920310002726"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-0967-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:58:40Z","timestamp":1694771920000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-0967-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-0967-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects. The present study was approved by the Ethics Review Committee of University of Ioannina. No additional permissions were required to review the patient records, including the hospitals from which the records were obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}